Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan C. Fox currently holds 24,833 shares of Eidos Therapeutics, Inc. (EIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan C. Fox has been a net seller of EIDX stock. They have purchased $330.4K and sold $7.3M worth of shares.
Jonathan C. Fox's most recent insider trade was on Jul 1, 2026, when they sold 319 shares at $0.00 per share.
Jonathan C. Fox serves as Executive at Eidos Therapeutics, Inc. (EIDX). They have executed 54 insider transactions totaling $7.6M over their tenure at the company.
Jonathan C. Fox holds the position of Executive at Eidos Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Jonathan C. Fox has shown a selling trading pattern, with $330.4K in total purchases and $7.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan C. Fox was on Jul 15, 2019, when they sold $600.6K worth of EIDX shares. This transaction involved 15,000 shares at $40.04 per share.
Jonathan C. Fox currently owns 24,833 shares of Eidos Therapeutics, Inc. (EIDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan C. Fox's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan C. Fox has 54 Form 4 filings on record as an insider at Eidos Therapeutics, Inc..
Set alerts for Jonathan C. Fox and 40,000+ other insiders.